Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D-2 and Histamine H-3 Receptors: A PET Study in Healthy Rats

Nafiseh Ghazanfari, Aren van Waarde, Janine Doorduin, Jurgen W. A. Sijbesma, Maria Kominia, Martin Koelewijn, Khaled Attia, David Vallez-Garcia, Antoon T. M. Willemsen, André Heeres, Rudi A. J. O. Dierckx, Ton J. Visser, Erik F.J. de Vries, Philip H. Elsinga*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
105 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D-2 and Histamine H-3 Receptors: A PET Study in Healthy Rats'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Keyphrases